戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  Z materials resulting in the release of the Auger electrons.
2 condary electron cascading initiated by slow Auger electrons.
3 11)In emits gamma-photons and conversion and Auger electrons.
4 emits a substantial number of conversion and Auger electrons.
5  emits a higher percentage of conversion and Auger electrons.
6 1)Tb's additional emission of conversion and Auger electrons.
7 uggesting additional cell membrane damage by Auger electrons.
8 he high cytotoxicity of conversion electrons/Auger electrons, (161)Tb is promising for radioimmunothe
9  64% was from conversion electrons, 16% from Auger electrons, 20% from gamma-photons and x-rays, resp
10                                              Auger electron (AE) radiopharmaceutical therapy (RPT) ma
11 ys to (134)La via electron capture, emitting Auger electrons (AEs), which could be used for targeted
12               When delivered by Ab LL1, both Auger electron and beta-particle emitters can produce sp
13 medium-energy beta(-) emission with those of Auger electrons and emits fewer photons than (111)In.
14 substantial emission of conversion electrons/Auger electrons as well as beta(-) emission.
15 omising candidates for molecular imaging and Auger electron-based radionuclide therapy.
16 prepared with (57)Co or (58m)Co for SPECT or Auger electron-based therapy, respectively.
17 due to the additional emission of IC and not Auger electrons by (161)Tb.
18                In xenon clusters, photo- and Auger electrons contribute more significantly to the nan
19 entical final states created by a direct and Auger-electron emission, respectively.
20 e cancer cells because of its conversion and Auger-electron emission.
21 larly [(161)Tb]Tb-AMTG because of additional Auger-electron emissions at the cell membrane level.
22      When incorporated into DNA, short-range Auger electrons emitted by 125I-labeled IUdR can cause d
23              Conclusion: The IC, rather than Auger, electrons emitted by (161)Tb resulted in a higher
24 5-iodo-2'-deoxyuridine radiolabeled with the Auger electron emitter 123I or 125I (*IUdR).
25                        When labeled with the Auger electron emitter 123I or 125I, IUdR demonstrates t
26 5-iodo-2'-deoxyuridine radiolabeled with the Auger electron emitter 125I (125IUdR) is highly toxic to
27 cells to study the radiotoxic effects of the Auger electron emitter 125I delivered to the cells by OD
28 he radiopharmaceutical radiolabeled with the Auger electron emitter 125I was therapeutically effectiv
29 ith the beta-particle emitter (177)Lu or the Auger electron-emitter (111)In.
30 '- deoxyuridine (IUdR) radiolabeled with the Auger electron emitters 123I and 125I in several animal
31      When labeled with the subcellular range Auger electron emitters 125I and 123I, the thymidine ana
32 more specific in single-cell kill than other Auger electron emitters and beta-particle emitters, usin
33                The energy deposition of most Auger electron emitters at DNA scales of 2 nm or less ex
34 Instigated by the 2022 "Technical Meeting on Auger Electron Emitters for Radiopharmaceutical Developm
35                        Since this carrier of Auger electron emitters has antineoplastic effects ([123
36 r data demonstrate that the radiotoxicity of Auger electron emitters is determined by the radiation d
37 ors, but the high specificity indices of the Auger electron emitters may be an advantage.
38            Optimal cancer radiotherapy using Auger electron emitters requires selective localization
39                                              Auger electron emitters such as (125)I have a high linea
40 lioside, isotopes such as alpha-particle and Auger electron emitters with different radiation charact
41 gher levels of nonspecific toxicity than the Auger electron emitters, but both 131I and 90Y, and part
42 ody to CD74 (LL1) linked to (111)In or other Auger electron emitters.
43 -119 ((119)Sb) is one of the most attractive Auger-electron emitters identified to date, but it remai
44                 The therapeutic potential of Auger-electron emitting radionuclides is strongly depend
45 f tumor cells in vitro was achieved using an Auger electron-emitting antisense MORF oligomer administ
46  new alpha-particle-, beta(-)-particle-, and Auger electron-emitting radiometals-such as (67)Cu, (47)
47 ARP-targeting compounds radiolabeled with an Auger electron-emitting radionuclide can be trapped clos
48 ride (DTPA), allowing radiolabeling with the Auger electron-emitting radionuclide indium-111 ((111)In
49  been demonstrated that uptake of diagnostic Auger electron-emitting radionuclides by male germ cells
50 mor cells and therefore may be used to carry Auger electron-emitting radionuclides such as (111)In fo
51 cerns the testicular uptake and dosimetry of Auger electron-emitting radionuclides that are used duri
52             In this study, the virtues of 12 Auger electron-emitting radionuclides were evaluated in
53       To elucidate potential benefits of the Auger-electron-emitting radionuclide (161)Tb, we compare
54 possible to obtain a therapeutic effect from Auger-electron-emitting radionuclides administered at ra
55 d a two-step targeting strategy to transport Auger-electron-emitting radionuclides into the cell nucl
56  physics presented here could be expanded to Auger electron excitation, x-ray emission, and electron
57 istics of which include emission of B(-) and Auger electrons for radiotherapy and B(+) particles for
58 ta(-)-emitter with additional conversion and Auger electrons) in a cluster of 19 cells (14-mum diamet
59 -coating thickness profiles obtained through Auger electron microscopy (AEM).
60 onsidered and is a direct consequence of the Auger electrons playing less of a role for clusters comp
61              We have simulated the oxygen 1s Auger-electron spectra of normal and heavy liquid water
62 situ low-energy electron diffraction (LEED), Auger electron spectroscopy (AES), and low-energy ion sc
63 copy (EDS) and a quantitative measurement by Auger electron spectroscopy (AES).
64                                              Auger electron spectroscopy is applied to demonstrate a
65 emical analysis with X-ray photoelectron and Auger electron spectroscopy on model dense thin films an
66 ycrystalline alloys are studied by utilizing Auger electron spectroscopy, low energy ion scattering s
67 RS intensities, hydrogen TPD peak areas, and Auger electron spectroscopy, quantitative estimates of t
68 otron X-ray diffraction, Raman spectroscopy, Auger electron spectroscopy, secondary ion mass spectrom
69 electric effects that include the release of Auger electrons that can induce localized DNA breaks.
70 I produces a shower of low energy electrons (Auger electrons) that cause strand breaks in DNA in a di
71 clides as well as radionuclides suitable for Auger electron therapies.
72 py theranostic pair with (225)Ac or as a PET/Auger electron therapy theranostic pair with (135)La.
73 py theranostic pair with (225)Ac or as a PET/Auger electron therapy theranostic pair with (135)La.
74 high ionizing potential and short range lead Auger electrons to kill cancer cells through the creatio
75 amma-rays, (161)Tb also emits conversion and Auger electrons, which may be particularly effective to
76 l radionuclides used in medical imaging emit Auger electrons, which, depending on the targeting strat
77 uclide that emits both beta(-) particles and Auger electrons with high linear energy transfer, potent
78 emission of ultra-short-range conversion and Auger electrons, with its medium-energy beta(-)-particle
79  Exposure of Gd-NPs to (177)Lu increased the Auger electron yield but not the absorbed dose.